Years of research by world class scientists
Our Mission
To unlock the benefits of nature and improve the lives of billions

Our Team
The beating heart of Nuritas is our incredibly passionate team.
We have an international team comprising over 16 different nationalities with offices in Dublin and Boston. We are also very proud of our gender balance with 50% women and men across the team.
Our Data Scientists, Biologists, AI Engineers, Chemists, Commercial and Operations teams bring innovation, passion and flexibility to their work every day.
860
593
65
Our history
- Nuritas Founded2014
- Nuritas raises $5M in seed capital2016Full integration of AI system and wet lab
- $20M raised through Series A2017Collaboration with BASF
Johnson & Johnson innovation award
- Collaboration with Nestle2019Launch of PeptAIde, first AI discovered health product
- Launch of Nuritas ingredient product range2020
- $45M raised through Series B2021Collaboration with Sumitomo Chemical
Our Teams
Advisory Board


Board

Some of Nora’s publications have been placed in a library of the top 2% of published articles in the fields of biology and medicine.
Throughout her career, Nora’s ambition has been to disrupt the status quo in areas that have been void of technology by introducing new ways of thinking, big data, and new algorithms.
Previous to Nuritas™, Nora was the first scientist to show gene transfer between multi-cellular species. This groundbreaking find put into question many of the phylogenetic methods currently in use today.
Nora has developed a multitude of innovative software throughout her research career that are used to this day by research institutes and companies in over 70 countries. Nora has led international research teams around the world, in both academic and industrial settings, and has a proven record in new health-benefiting molecule discovery and commercialisation.
Over the next few years, Nora plans to lead the Nuritas™ team in their goal of reaching billions of people with their life-changing ingredients.

Prior to founding NPC in 2014, Matthieu was with Everest Capital, a large independent investment firm with offices in the US and in Singapore, for over 16 years. At Everest Capital, he was a Senior Managing Director and the Director of Research as well as a member of the Executive and Investment committees. Prior to Everest, Matthieu was with Banque Paribas, in Hong Kong, New York, Taipei and Paris.

Prior to forming Sandbox, Nick led the buyout and served as CEO of The NutraSweet Company. As a senior executive at Monsanto, he led the Nutrition and Consumer Products division, overseeing NutraSweet, the consumer Lawn and Garden Business, and Kelco food ingredients business. Nick also served as a Senior Vice President and Advisor to the Board of Directors at Monsanto.
Previously, Nick held senior executive positions at Searle and has experience with Masonite Corporation and Baxter. He has lived and worked in several countries, including Kuwait, Switzerland and France. Nick has also been involved with numerous civic and commercial organizations. Nick holds a B.S. in Political Science from Northern Illinois University and an MBA from DePaul University.
Matthieu has a postgraduate degree in Corporate Finance from Université Paris Dauphine and has a graduate degree from Institut d’Etudes Politiques de Paris (Sciences Po).
Stephan has worked with entrepreneurial growth companies since the 1980s. He has been a private equity investor since 1999, investing in software, communications technology, biotechnology, clean energy and agricultural businesses. He led VantagePoint Capital Partners' $1Bn CleanTech Fund from its inception. More recently he served as a senior advisor in forming the Breakthrough Energy Ventures fund and was the Managing Partner of Resourcient Group LLC. Stephan has also acted as co-founder of several companies and has helped "raise" five "unicorn" companies reaching valuations of between $1 and $100bn.
Stephan is a graduate of the School of Architecture at the University of Virginia (BCP) and the University of Virginia School of Law (JD).

He obtained his Bachelor of Science degree in General Management/Accounting and MBA in Finance from Purdue University.
Team
Some of Nora’s publications have been placed in a library of the top 2% of published articles in the fields of biology and medicine.
Throughout her career, Nora’s ambition has been to disrupt the status quo in areas that have been void of technology by introducing new ways of thinking, big data, and new algorithms.
Previous to Nuritas™, Nora was the first scientist to show gene transfer between multi-cellular species. This groundbreaking find put into question many of the phylogenetic methods currently in use today.
Nora has developed a multitude of innovative software throughout her research career that are used to this day by research institutes and companies in over 70 countries. Nora has led international research teams around the world, in both academic and industrial settings, and has a proven record in new health-benefiting molecule discovery and commercialisation.
Over the next few years, Nora plans to lead the Nuritas™ team in their goal of reaching billions of people with their life-changing ingredients.
Owen joined Nuritas in 2020, having spent the previous 5 years as CFO of a Global eCommerce and AI Technology start-up. Prior to that, he was CFO of an international FMCG business with customers such as Tesco, M&S, Aldi and Lidl. He also served time as the Finance Director of an IT multinational services company with major global customers such as Dell, Intel and Apple.
Owen has an MBA from Dublin City University and also completed the Stanford Graduate School of Business Strategic Leadership for CFO's programme.
Owen has negotiated Long Term Agreements with some of the largest Technology and Retail Companies in the world and has extensive M&A and fundraising experience to fund global growth.
Prior to joining Nuritas, Bernard was a senior adviser at Granahan McCourt, a private investment firm focused on connecting people to innovation in technologically underserved areas of the world. He served as General Counsel of enet, the leading wholesale communications provider in Ireland, and sat on the boards of several other entities in which Granahan McCourt held investments.
Previously, Bernard held leadership roles with global communications firms Level 3 and Global Crossing. He was General Counsel at ComReg, regulator of the communications and postal sectors in Ireland, and held various roles at William Fry, a leading international law firm.

Investors











Ali Partovi

Bono

Edge
